Vasculitis

A new simulation model can predict a range of clinical outcomes for various therapy strategies in patients with ANCA-associated vasculitis, according to data published in Arthritis Care & Research.

Patients who have received a COVID-19 vaccine demonstrate a “slight but significant” change of developing IgA vasculitis, but no more than with other vaccines, according to data published in the Journal of Rheumatology.

PHILADELPHIA — An initial double dose of pneumococcal vaccine improves immune response against pneumococcal pneumonia in patients with ANCA-associated vasculitis treated with rituximab, according to data presented at ACR Convergence 2022.

PHILADELPHIA — Patients who are diagnosed with ANCA-associated vasculitis at an older age are more likely to accrue higher levels of systemic damage than patients diagnosed at a younger age, according to data presented at ACR Convergence 2022.

PHILADELPHIA — In children with acute Kawasaki disease where fever symptoms have resolved, continued daily monitoring for 1 to 2 weeks is strongly recommended, according to new guidelines released during ACR Convergence 2022.

Following the Supreme Court’s decision in June overturning Roe v. Wade, communication regarding effective and safe birth control in certain patients, including those with lupus and other rheumatic disease, has become immensely important.